Article dwells upon the research of urgent problems of formation and development of high-tech sectors (pharmaceutics and biotechnology). The work reveals peculiarities of the aforementioned fields in the EU countries as priorities for economic development. Author defined within the framework of The Ukraine–European Union Association Agreement the implementation of international norms and standards in the national legal system.
Complex of plans for further promising development of pharmaceutics and biological fields in Ukraine in cooperation with the EU have been suggested and grounded.
Androshchuk, H. (2009). Germany’s innovative development programme: high technology strategy. Nauka i innovatsii – Science and Innovation, 5, 3, 72-88 [in Ukrainian]
Barmina, A. (2014). Regulatory policy in the pharmaceutical sector: problems and ways of their solution. Ezhenedel’nik APTEKA, 3 [in Russian]
Dmitrik, E. (2014). R&D-activity of pharmaceutical and biotechnological companies. Ezhenedel’nik APTEKA, 8 [in Russian]
Shchegol’, S. (2013). R&D-activity of pharmaceutical market in 2012. Ezhenedel’nik APTEKA, 32 [in Russian]
The German Biotechnology Sector 2013. URL: http://www.biotechnologie.de/
Fedulova, L.I. (Ed.). (2013). The regional innovation system of Ukraine: state formation and development under the conditions of integration challenges: monograph. Kyiv: Institute for Economics and Forecasting, National Academy of Sciences of Ukraine [in Ukrainian]
Hruzdova, T. (2014). Commercialization of the intellectual activity results at the leading enterprises of the pharmaceutical industry. Problemy nauky, 4-5 (160-161), 9-15 [in Ukrainian]
Materials of the round table ‘European integration of pharmaceutical industry in Ukraine’. URL: http://www.gmpcenter.org.ua/ [in Ukrainian]
Ukraine and European Union. URL: http://www.3w. mk.ua/Site3W/00000126.htm [in Ukrainian]